Skip to main content
. 2021 Feb 19;11(2):345. doi: 10.3390/diagnostics11020345
ADT Androgen-Deprivation Therapy
AR Androgen Receptor
ARSi Androgen-Receptor Signaling Inhibitors
AR-V7 Androgen-receptor Splice Variant 7 messenger RNA
ASCO American Society Clinical Oncology
ASR Age Standardized Rate
BS Bone Scintigraphy
CRPC Castration-Resistant Prostate Cancer
CSPC Castration-Sensitive Prostate Cancer
CT Computed Tomography
dMMR Mismatch Repair Deficient
EAU European Association of Urology
FDA US Food and Drug Administration
MSI-H Microsatellite instability-high
mCRPC Metastatic Castration-Resistant Prostate Cancer
mCSPC Metastatic Castration-Sensitive Prostate Cancer
MRI Magnetic Resonance Imaging
PCa Prostate Cancer
PET Positron Emission Tomography
PS Performance Status
PSMA Prostate-Specific Membrane Antigen
PSA Prostate-Specific Antigen
RTC Randomized Controlled Trials
SOC Standard of Care
USPSFR US Preventative Services Task Force